LAUSR

Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes

Sign Up to like & get
recommendations!
1 Published in 2022 at "Pharmaceuticals"

DOI: 10.3390/ph15101242

Abstract: Pulmonary hypertension (PH) is characterized by a resting mean pulmonary artery pressure (PAP) of 20 mmHg or more and is a disease of multiple etiologies. Of the various types of PH, pulmonary arterial hypertension (PAH)… read more here.

Keywords: pulmonary hypertension; hypertension; therapies pulmonary; strategizing drug ... See more keywords